NCT05852314

Brief Summary

The aim of this study is to determine the feasibility and acceptability of culturally adapted CMAP for suicidal Ideation for women in postnatal period. Objectives

  1. 1.To adapt existing CMAP Intervention for suicidal ideation (CMAP-SI) in postnatal period.
  2. 2.To investigate whether CMAP-SI is feasible and acceptable among women presenting suicidal Ideations in postnatal period; and
  3. 3.To test whether there is an indication for the effects of the CMAP in reducing suicidal thoughts among women in postnatal period.
  4. 4.To explore participants experiences with CMAP-SI Intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

1.4 years

First QC Date

May 1, 2023

Last Update Submit

August 9, 2024

Conditions

Keywords

Postnatal DepressionSuicidal IdeationLMICsCMAP

Outcome Measures

Primary Outcomes (1)

  • Feasibility and Acceptability

    The feasibility is defined as engagement with the intervention, its usability in daily life, as well as its potential for delivering a full trial in future. The feasibility of the study procedures will be assessed through monitoring recruitment and retention rates. Acceptability operationalised as the extent to which the participants receiving the intervention considered it to be appropriate, will be assessed through each participant's attendance rates in the intervention session. Additionally, the feasibility and acceptability will also be measured through qualitative interviews at post intervention

    At 3 months after baseline

Secondary Outcomes (7)

  • Beck Scale for Suicidal Ideation (BSS) (Beck et al., 1988)

    Baseline and 3 months

  • Suicide Attempt and Self-Harm (SASH) (Eylem, 2011)

    Baseline and 3 months

  • Edinburgh postnatal depression scale (EPDS) (Cox et al., 1987)

    Baseline and 3 months

  • Beck Depression Inventory (BDI) (Beck et al., 1961)

    Baseline and 3 months

  • Life Events Checklist (Husain et al., 2000)

    Baseline and 3 months

  • +2 more secondary outcomes

Study Arms (2)

Culturally Adapted Manual Assisted Therapy (CMAP-SI)

EXPERIMENTAL

Participants in this arm will be offered the CMAP-SI intervention. The intervention will be delivered by trained researchers.

Behavioral: Culturally Adapted Manual Assisted Therapy (CMAP-SI)

Treatment as Usual (TAU)

NO INTERVENTION

Local medical, psychiatric, and primary care services provide standard routine care in Pakistan. Participants will receive an initial assessment along with TAU as ascertained by their treating primary care physician (General Practitioner, GP). As part of the safety protocol, we will obtain the contact details of the participants GP. We will also obtain the details of any treatment received by each participant. Research psychologists delivering the interventions will not be involved with the participants allocated to the TAU.

Interventions

C-MAP has been adapted from a self-help guide called Life After Self-Harm based on the principles of CBT. It is a brief problem-solving therapy comprising have 4 sessions weekly and then 4 fortnightly and last about 50 minutes each. The manual has been translated to Urdu giving special consideration to cultural adaptation of phrases and concepts to reflect Pakistani culture. Additionally, culturally appropriate case scenarios were incorporated and a consensual view to addressing cultural factors such as gender role, family conflicts and financial difficulties was taken. The culturally adapted intervention consists of the following components: evaluation of self-harm attempt, crisis skills, problem-solving and CBT techniques to manage emotions, negative thinking, interpersonal relationships, and relapse prevention strategies. Participants will receive sessions according to adapted CMAP-SI manual.

Culturally Adapted Manual Assisted Therapy (CMAP-SI)

Eligibility Criteria

Age16 Years - 44 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 44-year-old mothers with children 0 - 30 months old
  • Residents of the trial site catchments area
  • Able to provide informed consent
  • Presenting with suicidal ideation as measured by the Beck Suicidal Ideation Scale (BSSI) (must score 1 or 2 on item 4 and 5)
  • Not requiring in-patient psychiatric treatment.

You may not qualify if:

  • We will exclude mothers with any physical or psychiatric condition severe enough to prevent study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benazir Bhutto Hospital

Rawalpindi, Punjab Province, Pakistan

RECRUITING

MeSH Terms

Conditions

Depression, PostpartumSuicidal Ideation

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental DisordersSuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Nasim Chaudhry, MD

    Pakistan Institute of Living and Learning

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tayyaba Kiran, PhD.

CONTACT

Rabia Sattar, PhD. Cont.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2023

First Posted

May 10, 2023

Study Start

July 10, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations